Literature DB >> 23047665

Acrolein induction of oxidative stress and degranulation in mast cells.

Daniel J Hochman1, Christopher R Collaco, Edward G Brooks.   

Abstract

Increases in asthma worldwide have been associated epidemiologically with expanding urban air pollution. The mechanistic relationship between airway hyper-responsiveness, inflammation, and ambient airborne triggers remains ambiguous. Acrolein, a ubiquitous aldehyde pollutant, is a product of incomplete combustion reactions. Acrolein is abundant in cigarette smoke, effluent from industrial smokestacks, diesel exhaust, and even hot oil cooking vapors. Acrolein is a potent airway irritant and can induce airway hyper-responsiveness and inflammation in the lungs of animal models. In the present study, we utilized the mast cell analog, RBL-2H3, to interrogate the responses of cells relevant to airway inflammation and allergic responses as a model for the induction of asthma-like conditions upon exposure to acrolein. We hypothesized that acrolein would induce oxidative stress and degranulation in airway mast cells. Our results indicate that acrolein at 1 ppm initiated degranulation and promoted the generation of reactive oxygen species (ROS). Introduction of antioxidants to the system significantly reduced both ROS generation and degranulation. At higher levels of exposure (above 100 ppm), RBL-2H3 cells displayed signs of severe toxicity. This experimental data indicates acrolein can induce an allergic inflammation in mast cell lines, and the initiation of degranulation was moderated by the application of antioxidants.
Copyright © 2012 Wiley Periodicals, Inc., a Wiley company.

Entities:  

Keywords:  acrolein; air pollution; allergic inflammation; cellular toxicity; cytokines; degranulation; mast cell; oxidative stress

Mesh:

Substances:

Year:  2012        PMID: 23047665     DOI: 10.1002/tox.21818

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  11 in total

Review 1.  Molecular mechanisms of acrolein toxicity: relevance to human disease.

Authors:  Akshata Moghe; Smita Ghare; Bryan Lamoreau; Mohammad Mohammad; Shirish Barve; Craig McClain; Swati Joshi-Barve
Journal:  Toxicol Sci       Date:  2015-02       Impact factor: 4.849

2.  Rapamycin inhibits acrolein-induced apoptosis by alleviating ROS-driven mitochondrial dysfunction in male germ cells.

Authors:  X He; W Song; C Liu; S Chen; J Hua
Journal:  Cell Prolif       Date:  2014-01-31       Impact factor: 6.831

3.  A Potential Role for Acrolein in Neutrophil-Mediated Chronic Inflammation.

Authors:  Brett D Noerager; Xin Xu; Virginia A Davis; Caleb W Jones; Svetlana Okafor; Alicia Whitehead; J Edwin Blalock; Patricia L Jackson
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

4.  Impact of fossil fuel emissions and particulate matter on pulmonary health.

Authors:  Jonathan Kopel; Gregory L Brower
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-05

Review 5.  Dural Immune Cells, CGRP, and Migraine.

Authors:  Louis K Balcziak; Andrew F Russo
Journal:  Front Neurol       Date:  2022-03-31       Impact factor: 4.086

6.  Enhancement of the acrolein-induced production of reactive oxygen species and lung injury by GADD34.

Authors:  Yang Sun; Sachiko Ito; Naomi Nishio; Yuriko Tanaka; Nana Chen; Lintao Liu; Ken-ichi Isobe
Journal:  Oxid Med Cell Longev       Date:  2015-03-03       Impact factor: 6.543

7.  Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention.

Authors:  Takuro Nishikawa; Emiko Miyahara; Koichiro Kurauchi; Erika Watanabe; Kazuro Ikawa; Kousuke Asaba; Takayuki Tanabe; Yasuhiro Okamoto; Yoshifumi Kawano
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 8.  Mast cell mediators: their differential release and the secretory pathways involved.

Authors:  Tae Chul Moon; A Dean Befus; Marianna Kulka
Journal:  Front Immunol       Date:  2014-11-14       Impact factor: 7.561

9.  Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects.

Authors:  Marie-Laure Crouch; Gary Knowels; Rudolph Stuppard; Nolan G Ericson; Jason H Bielas; David J Marcinek; Karen L Syrjala
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

10.  Drug induced Kounis syndrome: does oxidative stress play a role?

Authors:  Luisa Ricciardi; Fabiana Furci; Marco Casciaro; Eleonora Di Salvo; Mariateresa Cristani; Valeria Tigano; Paola Lucia Minciullo; Sebastiano Gangemi
Journal:  Clin Mol Allergy       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.